Adenosine bronchoprovocation: A promising marker of allergic inflammation in asthma?

Thorax

Volumn 52, Issue 10, 1997, Pages 919-923

  Polosa, Riccardo ^a   Holgate, Stephen T ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE PHOSPHATE; HISTAMINE;

ALLERGY; ASTHMA; ATOPY; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ACTIVITY; DISEASE MARKER; HISTAMINE RELEASE; INFLAMMATION; MAST CELL; PRIORITY JOURNAL; REVIEW;

EID: 0030783540     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.10.919     Document Type: Review

References (63)

1. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-57.
2. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 1993;148:91 7.
3. Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance m normal and asthmatic subjects. Br J Clin Pharmacol 1983;15:161 5.
4. Crimi N, Polosa R, Mistretta A. Mechanisms of the effector function of adenosine in asthma and rhinitis. Drug Dev Res 1993;28:322 7.
5. Nyce JW, Metzger WJ. DNA antisense therapy for asthma in an animal model. Nature 1997;385:721-5.
6. Ali S, Mustafa SJ, Driver AG, Metzger WJ. Release of adenosine in bronchoalveolar lavage fluid following allergen bronchial provocation in allergic rabbits. Am Rev Respir Dis 1991;143:A417.
7. Marquardt DL, Gruber HE, Wasserman ST. Adenosine released from stimulated mast cells. Prot Nutl Acad Sci USA 1984;81:6192-6.
8. Montefort S, Gratziou C, Goulding D, Polosa R, Haskard DO, Howarth PH, et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules six hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest 1994;93:1411 21.
9. Madara JL, Patapoff TW, Gillece-Castro B, Colgan SP, Parkos CA, Delp C, et al. 5′-AMP is the neutrophilderived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J Clin Invest 1993;91:2320 5.
10. Laitinen LA, Heino M, Laitenen A, Kava T, Hauhtela T. Damage to the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985;131: 599-606.
11. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
12. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J 1986;233:309 19.
13. Watt AH, Penny WJ, Singh H, Routledge PA, Henderson AH. Adenosine causes transient dilation of coronary arteries in man. Br J Clin Pharmacol 1987;24:665-8.
14. Rose FR, Hirshhorn R, Weissman G, Cronstein BN. Adenosine promotes neutrophil chemotaxis. J Exp Med 1988; 167:1186 94.
15. 2-receptor mediated mechanism. Br J Pharmacol 1983;80:719-26.
16. 2-purinoceptor mediated mechanism. Biochem Pharmacol 1984;33:3847 52.
17. Peachell PT, Columbo M, Kagey-Sobotka A, Lichtenstein LM, Marone G. Adenosine potentiate mediator release from human lunq mast cells. Am Rev Respir Dis 1988;138: 1141-51.
18. 2h receptors evoke IL-8 secretion in human mast cells. J Clin Invest 1995;96: 1079-86.
19. Polosa R. Renaissance of the effector role of the mast cell in bronchial asthma. Ann Ital Med Int 1995;10:126 33.
20. Mann JS, Holgate ST. Specific antagonism of adenosine-induced bronchoconstriction in asthma by oral theophylline. Br J Clin Pharmacol 1985;19:685-92.
21. Clarke H, Cushley MJ, Persson CG, Holgate ST. The protective effects of intravenous theophylline and enprofylline against histamine- and AMP-provoked bronchoconstriction: implications for the mechanisms of action of xanthine derivatives in asthma. Pulm Pharmacol 1989; 2:147 54.
22. Mann JS, Holgate ST, Renwick AG, Cushley MJ. Airway effect of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 1986; 61:1667-76.
23. Forsythe P, McGarvey LPA, Heaney LG, MacMahon J, Ennis M. Adenosine stimulates human pulmonary mast cells. Thorax 1995;50(Suppl 2):P132.
24. Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by antiallergic drugs and salbutamol. Br J Pharmacol 1987;90: 421-9.
25. Phillips GD, Scott VL, Richards R, Holgate ST. Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5′-monophosphate. Eur Respir J 1989;2:210 7.
26. Phillips GD, Finnerty JP, Holgate ST. Comparative protective effect of the inhaled beta2-agonist salbutamol on bronchoconstriction provoked by histamine, methacholine and adenosine 5′-monophosphate in asthma. J Allergy Clin Immunol 1990;85:755 62.
27. Phillips GD, Rafferty P, Beasley CRW, Holgate ST. The effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5′-monophosphate in non-atopic asthma. Thorax 1987;42:939-45.
28. Rafferty P, Beasley CRW, Holgate ST. The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5′-monophosphate in atopic asthma. Am Rev Respir Dis 1987;136:369 73.
29. Crimi N, Palermo F, Polosa R, Oliveri R, Maccarrone C, Palermo B, et al. Effect of indomethacin on adenosineinduced bronchoconstriction. J Allergy Clin Immunol 1989; 83:921 5.
30. Phillips GD, Holgate ST. The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5′-monophosphate in non-atopic asthma. Am Rev Respir Dis 1989;139:463-9.
31. Crimi N, Polosa R, Magri S, Prosperini G, Milazzo LV, Santonocito G, et al. Inhaled lysine-acetylsalicylate (LASA) attenuates the bronchoconstrictor response to AMP in asthmatic subjects. Eur Respir J 1995;8:905 12.
32. van Schoor J, Joos GF, Kips JC, Drajesk JF, Carpentier PJ, Pauwels RA. The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1997;155:875 80.
33. Polosa R, Magri S, Vancheri C, Armato F, Santonocito G, Mistretta A, et al. Time course of changes in AMP airway responsiveness with inhaled heparin in allergic asthma. J Allergy Clin Immunol 1997;99:338-44.
34. Phillips GD, Ng WH, Church MK, Holgate ST. The response of plasma histamine to bronchoprovocation with methacholine, adenosine 5′-monophosphate and allergen in atopic non asthmatic subjects. Am Rev Respir Dis 1990; 141:9-13.
35. Polosa R, Ng WH, Crimi N, Vancheri C, Holgate ST, Church MK, et al. Release of mast cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med 1995;151:624-9.
36. Polosa R, Crimi N, Raccuglia D, Pagano C, Walters C, Church MK, et al. Histamine changes to nasal provocation with AMP and GMP in rhinitic and normal subjects. J Allergy Clin Immunol 1994;93:329.
37. Pauwels RA, Van der Straeten ME. An animal model for adenosine-induced bronchoconstriction. Am Rev Respir Dis 1987;136:374-8.
38. Polosa R, Phillips GD, Rajakulasingam K, Holgate ST. The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by AMP and histamine in asthma. J Allergy Clin Immunol 1991;87:939-47.
39. Polosa R, Lau LCK, Holgate ST. Inhibition of adenosine 5′-monophosphate- and methacholine-induced broncho-constriction in asthma by inhaled frusemide. Eur Respir J 1990;3:665-72.
40. O'Connor BJ, Chung FK, Miin Chen-Worsdell Y, Puller RW, Barnes PJ. Effect of inhaled furosemide and humetanide on AMP- and sodium metabisulphite-induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis 1991;143:1329 33.
41. Polosa R, Rajakulasingam K, Prosperini G, Church MK, Holgate ST. Relative potencies and time-course of changes in AMP airway responsiveness with inhaled frusemide and bumetanide in asthma. J Allergy Clin Immunol 1993,92: 288-97.
42. Rajakulasingam K, Polosa R, Church MK, Howarth PH, Holgate ST. Effect of inhaled frusemide on responses of airways to bradykinin and adenosine 5′-monophosphate in asthma. Thorax 1994;49:485-91.
43. Manzini S, Ballati L. 2-chloroadenosine induction of vagally-mediated and atropine-resistant bronchomotor responses in anaesthetised guinea pigs. Br J Pharmacol 1990; 100:251 6.
44. Meade CJ, Mierau J, Leon I, Ensinger HA. In vivo role of the adenosine A3 receptor: No-2-(4-aminophenyl) ethyladenosine induces bronchospasm in BDE rats by a neurally mediated mechanism involving cells resembling mast cells. J Pharmacol Exp Ther 1996;279:1148-56.
45. Polosa R, Rajakulasingam K, Church MK, Holgate ST. Repeated inhalation of bradykinin attenuates adenosine 5′-monophosphate (AMP) induced bronchoconstriction in asthmatic airways. Eur Respir J 1992;5:700-6.
46. Polosa R, Santonocito G, Magri S, Paolino G, Armato F, Pagano C, et al. A study of NEP inhibition with inhaled phosphoramidon on bronchial responsiveness to AMP in asthma. Eur Respir J 1997 (in press).
47. Hargreave FE, Ryan G, Thomson NC, O'Byrne PM, Latimer K, Juniper EF, et al. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981;68:347-55.
48. Casale TB, Wood D, Richerson HB, Trapp S, Metzger WJ, Zavala D, et al. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. J Clin Invest 1987;79:1197-203.
49. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988;137:62-9.
50. Robinson DS, Bentley AM, Hartnell A, Kay AB, Durham SR. Activated memory T helper cells in BAL fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax 1993; 48:26-32.
51. Bjorck T, Gustafsson LE, Dahlen SE. Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis 1992;145:1087-91.
52. Phillips GD, Holgate ST. Absence of a late response or increase in histamine responsiveness following bronchial provocation with AMP in atopic and non-atopic asthma. Clin Sci 1988;75:429-35.
53. Mann JS, Cushley MJ, Holgate ST. Adenosine-induced bronchoconstriction in asthma. Role of parasympathetic stimulation and adrenergic inhibition. Am Rev Respir Dis 1985;132:1-6.
54. Hoffman HM, Marquardt DL. The effect of adenosine on histamine release from allergen-sensitized mouse lung tissue. J Allergv Clin Immunol 1997;99(part 2):S89.
55. Oosterhoff Y, de Jong JW, Jansen MAM, Koeter GH, Postma DS. Airway responsiveness to AMP in chronic obstructive pulmonary disease is determined by smoking. Am Rev Respir Dis 1993;147:553-8.
56. Avital A, Springer C, Bar-Yishay E, Godfrey S. Adenosine, methacholine, and exercise challenges in children with asthma or pediatric chronic obstructive pulmonary disease. Thorax 1995;50:511-6.
57. Polosa R, Ciamarra I, Prosperini G, Pagano C, Vancheri C, Mistretta A, et al. Sputum eosinophilia correlates with bronchial responsiveness to AMP in patients with rhinitis. Am J Respir Crit Care Med 1997;155:A978.
58. O'Connor BJ, Ridge SM, Barnes PJ, Fuller RW. Greater effect of inhaled budesonide on AMP-induced than on sodium metabisulphite-induced bronchoconstriction in asthma. Am Rev Respir Dis 1992;146:560-4.
59. Polosa R, Rajakulasingam K, Prosperini G, Holgate ST. Budesonide attenutes bronchial reactivity to AMP to a greater extent than to methacholine in mild asthma. Thorax 1993;48:415P.
60. Doull IJM, Sandall BM, Smith S, Schreiber J, O'Toole S, Freezer J, et al. The effect of inhaled corticosteroids on bronchial responsiveness to adenosine 5′-monophosphate, methacholine and bradykinin in children. Am J Respir Crit Care Med 1997 (in press).
61. O'Connor BJ, Aikman S, Barnes PJ. Tolerance to the non-bronchodilator effects of inhaled beta-agonists in asthma. N Engl J Med 1992;327:1204 8.
62. O'Connor BJ, Fuller RW, Barnes PJ. Kon-bronchodilator effects of inhaled beta-agonists. Am J Respir Crit Care Med 1994;150:381-7.
63. van Velzen E, van den Bos J-W, Benckhuijsen JAW, van Essel T, de Bruijn R, Aalbers R. Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 1996;51:582-4.